Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ionis Pharmaceuticals
Ionis Pharmaceuticals
AstraZeneca, Ionis close deal on antisense therapy development
Pharmaceutical Business Review
Thu, 12/30/21 - 11:07 am
AstraZeneca
Ionis Pharmaceuticals
antisense
eplontersen
AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug
BioPharma Dive
Tue, 12/7/21 - 10:48 am
AstraZeneca
Ionis Pharmaceuticals
transthyretin amyloidosis
eplontersen
ANA 2021 – Ionis rocked by tofersen flop
EP Vantage
Mon, 10/18/21 - 10:58 am
Biogen
Ionis Pharmaceuticals
clinical trials
ALS
tofersen
Biogen leads the amyotrophic lateral sclerosis hopefuls
EP Vantage
Thu, 09/16/21 - 10:41 am
ALS
Amylx
Biogen
Ionis Pharmaceuticals
AB Science
Cytokinetics
Ionis collaborator Flamingo is ready to take flight with 3 antisense drugs in the clinic and mysterious RNA in its sights
Endpoints
Thu, 09/9/21 - 11:01 am
Ionis Pharmaceuticals
antisense
Flamingo Therapeutics
RNA
Biogen, Ionis tout data from early study of RNA-based Alzheimer's drug
BioPharma Dive
Tue, 07/27/21 - 04:31 pm
Biogen
Ionis Pharmaceuticals
Alzheimer's disease
BIIB080
Struggling Ionis licenses Bicycle Therapeutics' platform in a bid to develop drugs that can cross blood-brain barrier
Endpoints
Tue, 07/13/21 - 11:42 pm
Ionis Pharmaceuticals
Bicycle Therapeutics
blood-brain barrier
drug development
Ionis' Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More
BioSpace
Wed, 04/7/21 - 07:15 pm
Ionis Pharmaceuticals
Progenity
ALS
clinical trials
Ionis unveils positive PhII data for in-house rare disease drug, paving way to blockbuster rivalry with Takeda
Endpoints
Mon, 03/29/21 - 10:52 pm
Ionis Pharmaceuticals
clinical trials
IONIS-PKK-LRx
hereditary angiodema
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol
Ionis strikes deal to buy back lipid disease spinout Akcea
Fierce Biotech
Mon, 08/31/20 - 10:17 am
Ionis Pharmaceuticals
Akcea Therapeutics
M&A
lipid disease
Ionis deal delivers for GSK as HBV drug hits the mark in phase 2
Pharmaforum
Fri, 08/28/20 - 10:36 am
GSK
antisense
hepatitis B
clinical trials
GSK3228836
Ionis Pharmaceuticals
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects
Xconomy
Thu, 03/5/20 - 11:12 pm
Ionis Pharmaceuticals
Huntington's disease
clinical trials
tominersen
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia Treatment
Motley Fool
Wed, 01/29/20 - 10:42 am
Akcea Therapeutics
Ionis Pharmaceuticals
hypertriglyceridemia
AKCEA-ANGPTL3-Lrx
clinical trials
Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news
EP Vantage
Sun, 01/5/20 - 07:11 pm
Karyopharm
Xpovio
Multiple Myeloma
Pfizer
Akcea
Ionis Pharmaceuticals
AKCEA-ANGPTL3-Lrx
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease
BioSpace
Thu, 12/19/19 - 01:04 pm
Biogen
Alzheimer's disease
IONIS-MAPTRx
Ionis Pharmaceuticals
These Biotechs Were Focused on One Line on Pfizer’s Earnings Report
Motley Fool
Thu, 10/31/19 - 11:51 pm
Pfizer
Vyndaqel
Alnylam
Akcea Therapeutics
Ionis Pharmaceuticals
Eidos Therapeutics
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development
Endpoints
Wed, 10/9/19 - 09:46 am
Bayer
Ionis Pharmaceuticals
Factor XI
anti-thrombotics
clinical trials
IONIS-FXI-LR
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M
Xconomy
Mon, 10/7/19 - 11:18 am
Pfizer
Akcea
Ionis Pharmaceuticals
heart disease
AKCEA-ANGPTL3-Lrx
A Biotech Set to Dominate the Next 20 Years
Motley Fool
Tue, 10/1/19 - 10:53 pm
Ionis Pharmaceuticals
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »